Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 3
2012 3
2013 1
2014 2
2015 1
2016 3
2017 2
2018 5
2019 8
2020 13
2021 4
2022 6
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Cardiac pathology in spinal muscular atrophy: a systematic review.
Wijngaarde CA, Blank AC, Stam M, Wadman RI, van den Berg LH, van der Pol WL. Wijngaarde CA, et al. Among authors: wadman ri. Orphanet J Rare Dis. 2017 Apr 11;12(1):67. doi: 10.1186/s13023-017-0613-5. Orphanet J Rare Dis. 2017. PMID: 28399889 Free PMC article. Review.
Drug treatment for spinal muscular atrophy type I.
Wadman RI, Bosboom WM, van der Pol WL, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF. Wadman RI, et al. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006281. doi: 10.1002/14651858.CD006281.pub4. Cochrane Database Syst Rev. 2012. PMID: 22513939 Updated. Review.
Drug treatment for spinal muscular atrophy types II and III.
Wadman RI, van der Pol WL, Bosboom WM, Asselman FL, van den Berg LH, Iannaccone ST, Vrancken AF. Wadman RI, et al. Cochrane Database Syst Rev. 2020 Jan 6;1(1):CD006282. doi: 10.1002/14651858.CD006282.pub5. Cochrane Database Syst Rev. 2020. PMID: 32006461 Free PMC article.
Mastication in Patients with Spinal Muscular Atrophy Types 2 and 3 is Characterized by Abnormal Efficiency, Reduced Endurance, and Fatigue.
van der Heul AMB, van Eijk RPA, Wadman RI, Asselman F, Cuppen I, Nievelstein RAJ, Gerrits E, van der Pol WL, van den Engel-Hoek L. van der Heul AMB, et al. Among authors: wadman ri. Dysphagia. 2022 Aug;37(4):715-723. doi: 10.1007/s00455-021-10351-y. Epub 2021 Aug 15. Dysphagia. 2022. PMID: 34392389 Free PMC article. Review.
Longitudinal prospective cohort study to assess peripheral motor function with extensive electrophysiological techniques in patients with Spinal Muscular Atrophy (SMA): the SMA Motor Map protocol.
Ros LAA, Goedee HS, Franssen H, Asselman FL, Bartels B, Cuppen I, van Eijk RPA, Sleutjes BTHM, van der Pol WL, Wadman RI. Ros LAA, et al. Among authors: wadman ri. BMC Neurol. 2023 Apr 24;23(1):164. doi: 10.1186/s12883-023-03207-5. BMC Neurol. 2023. PMID: 37095427 Free PMC article.
Drug treatment for spinal muscular atrophy types II and III.
Wadman RI, Bosboom WM, van der Pol WL, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF. Wadman RI, et al. Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006282. doi: 10.1002/14651858.CD006282.pub4. Cochrane Database Syst Rev. 2012. PMID: 22513940 Updated. Review.
Population-based analysis of survival in spinal muscular atrophy.
Wijngaarde CA, Stam M, Otto LAM, van Eijk RPA, Cuppen I, Veldhoen ES, van den Berg LH, Wadman RI, van der Pol WL. Wijngaarde CA, et al. Among authors: wadman ri. Neurology. 2020 Apr 14;94(15):e1634-e1644. doi: 10.1212/WNL.0000000000009248. Epub 2020 Mar 26. Neurology. 2020. PMID: 32217777
Drug treatment for spinal muscular atrophy types II and III.
Wadman RI, Bosboom WM, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF. Wadman RI, et al. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006282. doi: 10.1002/14651858.CD006282.pub3. Cochrane Database Syst Rev. 2011. PMID: 22161400 Updated. Review.
51 results